Xenotransplantation and risk : regulating a developing biotechnology / Sara Fovargue.
By: Fovargue, Sara.
Cambridge ; New York : Cambridge University Press, 2012Description: xiii, 291 p. ; 24 cm.ISBN: 0521195764 (hardback); 9780521195768 (hardback).Subject(s): Transplantation immunology | Transplantation of organs, tissues, etc | Xenografts -- Moral and ethical aspects | Xenografts | Transplantation, Heterologous -- ethics | Transplantation, Heterologous -- legislation & jurisprudence | Transplantation, HeterologousGenre/Form: Print books.Current location | Call number | Status | Date due | Barcode | Item holds |
---|---|---|---|---|---|
On Shelf | QD188.8 .F58 2012 (Browse shelf) | Available | AU0000000001597 |
Browsing Alfaisal University Shelves , Shelving location: On Shelf Close shelf browser
QD181.C1 W37 2013 Graphene : fundamentals to applications / | QD181.C1 W65 2014 APPLICATIONS OF GRAPHENE. : AN OVERVIEW. | QD181.R1 C36 2015 Radium and the secret of life / | QD188.8 .F58 2012 Xenotransplantation and risk : regulating a developing biotechnology / | QD251.2 .W33 2022 Organic chemistry / | QD251.3 .D49 2006 Essentials of organic chemistry : for students of pharmacy, medicinal chemistry and biological chemistry / | QD251.3 .L46 2013 Advanced practical organic chemistry. |
Includes bibliographical references and index.
Introducing the issues -- Dealing with risk -- Regulating experimental procedures and medical research -- Regulatory responses to developing biotechnologies -- Challenges to legal and ethical norms : first party consent and third parties at risk -- Surveillance and monitoring : balancing public health and individual freedom -- Summary and concluding thoughts : looking to the future.
"Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health"--